AP1G1
protein-codingadaptor related protein complex 1 subunit gamma 1, the group of Clathrin/coatomer adaptor, adaptin-like, N-terminal domain containing|Adaptor related protein complex 1|Small nucleolar RNA protein coding host genes
Gene summary
Adaptins are important components of clathrin-coated vesicles transporting ligand-receptor complexes from the plasma membrane or from the trans-Golgi network to lysosomes. The adaptin family of proteins is composed of four classes of molecules named alpha, beta-, beta prime- and gamma- adaptins. Adaptins, together with medium and small subunits, form a heterotetrameric complex called an adaptor, whose role is to promote the formation of clathrin-coated pits and vesicles. The protein encoded by this gene is a gamma-adaptin protein and it belongs to the adaptor complexes large subunits family. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- CLAPG1
- ADTG
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~80.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: SD
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859196
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0859196
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*AP1G1* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2021 (Usmani et al., PMID: 34102099). Of note, *AP1G1* has also been implicated in autosomal recessive complex neurodevelopmental disorder (Usmani-Riazuddin syndrome, autosomal recessive). The split curation for Usmani-Riazuddin syndrome, autosomal recessive, is assessed separately. *AP1G1*-related autosomal dominant complex neurodevelopmental disorder (also known as Usmani-Riazuddin syndrome, autosomal dominant) is characterized by global developmental delay with variably impaired intellectual development, speech delay, and behavioral abnormalities, including aggression, hyperactivity, and autism spectrum disorder or autistic features. Additional common features include seizures, hypotonia, and distal limb anomalies. Five de novo missense variants and three de novo loss-of-function variants have been reported in nine unrelated patients (PMID: 34102099). This gene-disease relationship is also supported by experimental evidence. AP1G1 interacts with other adaptor protein complex 1 (AP-1) proteins, AP1S1/AP1S2, which have been definitively implicated in neurodevelopmental disorders. AP complexes mediate selective intracellular vesicular trafficking and polarized localization of somatodendritic proteins in neurons. In summary, there is strong evidence to support this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 2, 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: ClinGen
*AP1G1* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2021 (Usmani et al., PMID: 34102099). Of note, *AP1G1* has also been implicated in autosomal dominant complex neurodevelopmental disorder (Usmani-Riazuddin syndrome, autosomal dominant). The split curation for Usmani-Riazuddin syndrome, autosomal dominant, is assessed separately. *AP1G1*-related autosomal recessive complex neurodevelopmental disorder (also known as Usmani-Riazuddin syndrome, autosomal recessive) has been reported in three affected individuals from two unrelated consanguineous families carrying homozygous missense variants functionally characterized in cell culture and zebrafish models (PMID: 34102099). Common features in affected individuals included global developmental delay, hypotonia, speech delay, moderately to severely impaired intellectual development, and spasticity. This gene-disease relationship is also supported by experimental evidence. AP1G1 interacts with other adaptor protein complex 1 (AP-1) proteins, AP1S1/AP1S2, which have been definitively implicated in neurodevelopmental disorders. AP complexes mediate selective intracellular vesicular trafficking and polarized localization of somatodendritic proteins in neurons. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 2, 2022 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0859174
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0859174
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AP1G1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001128.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 4 | 14 | 19 | ||
| missense | 3 | 3 | 129 | 31 | 166 | |
| nonsense | 5 | 3 | 8 | 16 | ||
| start loss | 0 | |||||
| frameshift | 5 | 2 | 7 | 14 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 8 | 12 | ||
| Total | 15 | 11 | 156 | 45 | 0 | 227 |
Highest pathogenic variant AF is 0.000008055591
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001119.3 | 22 | MANE Select | |
| Ensembl | ENSP00000299980.4 | 22 | MANE Select | |
| RefSeq | NP_001025178.1 | 23 | Standard | |
| Ensembl | ENSP00000377148.3 | 23 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ap1g1 | Danio rerio | Structure: blood cell Quality: mislocalised abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysosome - Homo sapiens (human)
- Golgi Associated Vesicle Biogenesis
- Lysosome Vesicle Biogenesis
- Clathrin derived vesicle budding
- Disease
Biological Process
- intracellular protein transport
- antigen processing and presentation of exogenous peptide antigen via MHC class II
- melanosome organization
- endosome to melanosome transport
- positive regulation of natural killer cell degranulation
Molecular Function
- transporter activity
- protein binding
- Rab GTPase binding
- kinesin binding
- GTP-dependent protein binding
Cellular Component
- Golgi membrane
- cytoplasm
- lysosomal membrane
- Golgi apparatus
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000393512
- Coding exons
- 23
- Length
- 80192
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125747
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.98 | 277 | 456 | 0.607 | 0.0000242 | 5382 |
| Missense (PolyPhen) | 47 | 158.58 | 0.29637 | 1872 | ||
| Synonymous | -0.303 | 165 | 160 | 1.03 | 0.00000796 | 1605 |
| Loss of Function | 6.05 | 5 | 52.2 | 0.0959 | 0.00000333 | 569 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000063 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules.;
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- LoFtool
- 0.247
- RVIS EVS
- -0.76
- RVIS percentile EVS
- 13.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.961
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |